India vs Sudan: The number of people with susceptibility test result for rifampicin
India
76.27
in 2021
Sudan
79.91
in 2021
India rank
98th
Sudan rank
96th
The number of people with susceptibility test result for rifampicin over time
- India
- Sudan
How they compare
Sudan currently reports 79.91 against 76.27 in India, a difference of 3.64.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was India ahead.
India ranks 98th and Sudan ranks 96th of 146 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.98 | 24.99 | 26.99 | India |
| 2020s | 87.02 | 72.49 | 14.53 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, India or Sudan?
- Sudan, at 79.91 against 76.27 in India as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between India and Sudan?
- 3.64, with Sudan ahead.
- How many years of comparable data are there for India and Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do India and Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- India ranks 98th and Sudan ranks 96th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.